MedAI Verdict
All comparisons

Cleerly vs Iterative Health

Cleerly analyzes coronary CT angiograms and SKOUT, the Iterative Health product, analyzes live colonoscopy video, so each lands in a different department. A cardiac imaging program that wants plaque volume, stenosis and ischemia likelihood from CCTA is Cleerly's buyer. openFDA lists six Cleerly 510(k)s, the latest two decided in July 2026, and CPT Category I code 75577 took effect in January 2026. An endoscopy center or GI group that wants polyp detection during the procedure is SKOUT's buyer. Its six clearances run from K213686 in August 2022 to K253664 in December 2025.

SKOUT's evidence is a sponsor-run randomized trial of 677 standard and 682 CADe colonoscopies. Adenomas per colonoscopy rose from 0.83 to 1.05 (P=.002) while the adenoma detection rate moved from 43.9% to 47.8% (P=.065). Cleerly's accuracy claim against FFRCT, drawn from the CREDENCE trial, is the vendor's own. Cleerly's home page and SKOUT's product page both send buyers to a demo request in place of a price.

Radiology · Reviewed November 2, 2026

Cleerly logo

Cleerly

by Cleerly

AI-driven CCTA plaque quantification + CAD staging.

Iterative Health logo

Iterative Health

by Iterative Health · founded 2017

Real-time AI polyp detection for colonoscopy with the FDA-cleared SKOUT system, for endoscopists and endoscopy centers.

When to pick each one

Cleerly

  • Coronary CT plaque, stenosis and ischemia analysis
  • PowerScribe reporting integration
  • CPT Category I code 75577 since January 2026
Read the full Cleerly review

Iterative Health

  • Real-time polyp detection on colonoscopy video
  • Six FDA 510(k) clearances, August 2022 to December 2025
  • Randomized trial raised adenomas per colonoscopy from 0.83 to 1.05
Read the full Iterative Health review

Score

Each row shows points earned of points available under the published rubric.

Cleerly

52of 100

Solid choice

Iterative Health

42of 100

Competitive
Score by dimension for Cleerly and Iterative Health
DimensionCleerlyIterative HealthDifference
FDA clearance18 / 1818 / 180
HIPAA / SOC2 / BAA0 / 100 / 100
EHR integrations (count)0 / 4.20 / 4.20
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.40 / 2.40
Peer-reviewed papers12.7 / 18.20 / 18.2+12.7
RCT / meta-analysis / systematic review3.9 / 7.80 / 7.8+3.9
Funding & adoption signal6 / 128.4 / 12-2.4
Pricing transparency2.5 / 52.5 / 50
Years in market0 / 66 / 6-6

Scroll horizontally to see every column.

How scores are computed

Pricing

Cleerly

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. The homepage offers a demo request.

Iterative Health

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. Demo request only.

Evidence

Iterative Health

FDA decisions

Show 1 more

Compliance and integrations

Documented from each vendor’s own pages.

SpecCleerlyIterative Health
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot specifiedNot specified
Foundedn/a2017
HQUSUS

Scroll horizontally to see both columns.

Common questions

Open the full radiology comparison

Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.